At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Audio processordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating Design Improvements With SONNET 3 in Experienced Cochlear Implant Users
In Brief
A clinical study evaluating Audio processor for Hearing Loss, Sensorineural. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedSep 2024
Enrollment StartDec 2024
Primary CompletionMay 2025
Study CompletionJul 2025
TodayJul 2026
First PostedSep 19, 2024
Enrollment StartDec 16, 2024
Primary CompletionMay 22, 2025
Study CompletionJul 31, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.8 years ago
Interventions
Audio processordevice
MED-EL SONNET 3 (EAS) audio processor